Evaluation of acute thrombus regression effect of anticoagulant for deep vein thrombosis in cancer patients
Not Applicable
- Conditions
- Deep vein thrombosis
- Registration Number
- JPRN-UMIN000036958
- Lead Sponsor
- Toho University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1 Patients who are contraindicated with heparin sodium and/or edoxaban 2 Patients judged as inappropriate by the research doctor
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Thrombus regression effect from 7 to 14 days after initiation of anticoagulation therapy
- Secondary Outcome Measures
Name Time Method